Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
D000328:Adult; D000379:Agoraphobia / Q000188:drug therapy*; D000525:Alprazolam; D001569:Benzodiazepines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005239:Fear / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D010200:Panic / Q000187:drug effects*; D010698:Phobic Disorders / Q000188:drug therapy*; D011569:Psychiatric Status Rating Scales; D013375:Substance Withdrawal Syndrome
D001569:Benzodiazepines; D000525:Alprazolam